Glatiramer multiple sclerosis

Common Questions and Answers about Glatiramer multiple sclerosis

copaxone

382218 tn?1341181487 php Long-Term Study With COPAXONE(R) Indicated Protective Effect On Brain Tissue In Multiple Sclerosis Patients Article Date: 29 Apr 2009 - 7:00 PDT "New data presented provided evidence that long-term treatment with COPAXONE® (glatiramer acetate injection) may offer sustained protection from neuronal/axonal injury.
4313204 tn?1353971047 Interferon Drugs for Multiple Sclerosis (Avonex, Betaseron, Rebif)Interferon beta drugs help control the immune system, which helps control MS. Glatiramer Glatiramer helps prevent the body's immune system from attacking nerve fibers. Novantrone Novantrone slows disability and reduces the relapse rate. Tysabri Therapy Tysabri reduces the relapse rate, but is somewhat controversial. Aubagio Aubagio reduces the number of flares in adults with relapsing forms of multiple sclerosis.
572651 tn?1530999357 Full story Two MS Drugs No Better than One NEW ORLEANS -- Among patients with relapsing-remitting multiple sclerosis, little clinical benefit was seen for combining glatiramer acetate with interferon beta-1a versus either drug alone in a large randomized trial.
378497 tn?1232143585 Hypointense lesions on T1 weighted MRI, referred to as black holes (BH), are a marker of demyelination/axonal loss in multiple sclerosis (MS). There is some evidence that glatiramer acetate (GA) may decrease the conversion of new brain lesions to BH. Methods: We used monthly 3 Tesla brain MRI scans for up to 2 years to study the development and evolution of new BH in 75 MS patients randomized to GA or Interferon {beta}-1b (IFNb1b) in the BECOME study.
Avatar m tn Using the EAE mouse model for multiple sclerosis (MS), the inventors have shown that the disease course and severity can be ameliorated with daily administration of antihistamine. This approach has the potential for treating MS with less side-effects and more convenient dosing than current therapeutic interventions. Stage of Research EAE mice treated daily with anti-histamine receptor 1 have decreased disease severity and delayed onset of the disease compared to controls.
382218 tn?1341181487 The ongoing US Glatiramer Acetate (GA) Trial is the longest evaluation of continuous immunomodulatory therapy in relapsing–remitting multiple sclerosis (RRMS). The objective of this study was to evaluate up to 15 years of GA as a sole disease-modifying therapy. Two hundred and thirty-two patients received at least one GA dose since study initiation in 1991 (mITT cohort), and 100 (43%, Ongoing cohort) continued as of February 2008.
Avatar n tn 38 Previously, various studies including the Controlled High Risk Avonex, Multiple Sclerosis Study, the Early Treatment of Multiple Sclerosis Study, the Betaseron in Newly Emerging Multiple Sclerosis for Initial Treatment Trial, the Prevention of Relapses and Disability by Interferon β-1a Subcutaneously in Multiple Sclerosis, and PreCISe trials have all helped to clarify the natural history of CIS including ON and management options for a single demyelinating episode.
Avatar m tn my sister (24) was diagnosed Multiple Sclerosis in 2010, responded to steroid. now she suffered sudden & complete loss of vision in her left eye. she has been put on SOLUMEDROL. please suggest any available treatment modalities world over ? chances of return of vision ??
Avatar f tn org/brochures and you can get many publications from The Basic Facts, The History of Multiple Sclerosis, to publications on Newly Diagnosed, Employment issues, Staying Well, Managing Specific Issues, Managing Major changes, And the list goes on and on.
Avatar m tn i had been diagonised with multiple sclerosis in the year 2001. now i am not able to walk. i am also not able to see clearly. my speech is also not clear. i think my type of ms is primary progressive since my condition has worsened gradually. pl suggest some medicines or other alternative therapy.